Ticker permalink · LEU
Nuclear / HALEU
American Centrifuge Operating (wholly owned) is the named recipient of the DOE HALEU commercial-capacity task order. The same award also appears as a USAspending new-prime row; it is one deal.
Same HALEU task order as the flagship row — counted once in the ranked screen.
THE PURPOSE OF THIS TASK ORDER (TO) IS TO ESTABLISH NEW ANNUAL DOMESTIC COMMERCIAL HIGH-ASSAY LOW-ENRICHED URANIUM (HALEU) CAPACITY AND BEGIN PRODUCTION OF HALEU UF6 FOR PURCHASE BY DOE.
If you bought LEU at the 2026-07-06 close after this deal was announced, the return to 2026-09-01 would have been -3.4%.
HALEU fixed-price task order to establish domestic commercial capacity. $900M FFP / $1.07B base+options.
If you bought LEU at the 2026-07-01 close after this deal was announced, the return to 2026-09-01 would have been 1.2%.
Close-to-close only. Ignores spreads, taxes, and whether you could fill. Not a forecast. Past ≠ future. A UCA or LOI announcement is not cash in the company. Not investment advice.